Pillars of Eternity 2: Deadfire has broken all records, raising $4.4 million from 33,00 backers in just a few weeks. The original goal was to raise $1.1 million, but through clever use of stretch goals — such as adding a player ship, extra companions to join you on your quest, and support for multiple languages — Obsidian Entertainment was able to gather four times that.

The first installment of Pillars of Eternity also was a record breaker, gathering just under $4 million on Kickstarter back in 2012 and to this day stands in that platform’s top 25 of best funded projects. Pillars of Eternity 2: Deadfire was funded through a new crowdfunding site, called Fig, which is different from Kickstarter as it only allows games to be funded, while also giving backers the option to buy equity in the projects and so, hopefully, make back their investment.

That the idea behind Fig is a good one is proven by the campaign for Pillars of Eternity 2: Deadfire, as not only is it the biggest success in the short history of the new site, it’s also the most successfully crowdfunded game of all time. Though $4.4 million pales beside the massive budgets that AAA studios have a their disposal, for a relatively small studio like Obsidian it’s an almost ridiculous amount of money. Currently, the studio still has a few stretch goals left, which, with some luck, should be able to carry the project up to the $5 million mark, which would likely assure the top spot for years to come.

When Pillars of Eternity 2: Deadfire is as yet unknown, though the developers have their work cut out for them; not only will the new game take place in an entirely new setting — the Deadfire Archipelago, far to the west of the first game’s Dyrwood — they have also promised a revamped UI and battle system plus a whole host of other small improvements. A few of the companions from one of the best RPGs of 2015 should be making a comeback as well, making the new game not just a sequel, but also a reunion.

Pillars of Eternity 2: Deadfire is currently in a development stage and has no release date yet.